Advertisement

Topics

Harbour BioMed Company Profile

22:32 EDT 17th October 2018 | BioPortfolio

Harbour BioMed is a global biopharmaceutical company discovering and developing innovative therapeutics for cancer, with a focus on immuno-oncology, and immunological diseases. The company's discovery and development programs are built around its two patented transgenic mouse platforms (Harbour Mice) for human antibody discovery. The company is building its proprietary pipeline through its innovative internal discovery programs, and through in-licensing clinical stage assets that strategically fit its internal portfolio. Harbour BioMed also licenses the platforms to companies and academic institutions through its Harbour Antibodies subsidiary. For additional information, please visit http://www.harbourbiomed.com.


News Articles [129 Associated News Articles listed on BioPortfolio]

Harbour BioMed Collaborates with WuXi Biologic for Supply of Novel Antibody

Harbour BioMed has formed an "initial strategic" collaboration with WuXi Biologics to develop clinical trial supplies of Harbour's leading HCAb antibody. Harbour, headquartered in the Boston area with...

Harbour BioMed gets rights to Glenmark's bispecific antibody

Glenmark Pharmaceuticals SA granted Harbour BioMed exclusive rights to develop and sell its bispecific antibody GBR1302 for solid tumors in Greater China. Harbour BioMed also retains a manufacturing o...

Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline

Harbour BioMed is engaged in the discovery and development of therapeutics for oncology and immunological diseases. The financing round was led by GIC Private Limited, and participants included The p...

Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology

Harbour BioMed has signed a collaboration agreement with Kelun-Biotech Biopharmaceutical to develop and commercialise A167, an anti-PD-L1 antibody indicated for...Read More... The post Deals this week...

Harbour BioMed signs $350m anti-PD-L1 deal with Kelun-Biotech

Chinese companies Harbour BioMed and Sichuan Kelun-Biotech Biopharmaceutical have entered into an exclusive strategic collaboration for the development and commercialisation...Read More... The post Ha...

Glenmark partners Harbour BioMed to develop oncology candidate in China

Glenmark Pharmaceuticals has signed an exclusive licence agreement with Harbour BioMed for the development, manufacture and commercialisation of its immuno-oncology...Read More... The post Glenmark pa...

Harbour BioMed, a US-China Company, Closes $85 Million Series B Round

Harbour BioMed completed an $85 million Series B financing, which it will use to advance its pipeline that includes both clinical and discovery stage programs. GIC, Singapore's sovereign wealth fund, ...

Harbour BioMed launches with $50mm Series A round

Harbour BioMed (cancer drug discovery) raised $50mm through its Series A round from Advantech Capital, Legend Capital, and company founders. The company its using its transgenic platforms in the disco...

Drugs and Medications [0 Results]

None

Clinical Trials [21 Associated Clinical Trials listed on BioPortfolio]

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

Endoscopic Resection of Gastric Subepithelial Masses, EndoResect Study

Gastric subepithelial masses might harbour gastrointestinal stromal tumors, which should get resected because of their malignant potential. To minimize the associated surgical trauma endos...

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

We hypothesize that all human malignancies harbour a subpopulation of tumor initiating cells/cancer stem cells (CSCs) that drives tumor development and potentially recurrence or metastasis...

Single-arm Trial of BIBW 2992 in Demographically and Genotypically Selected NSCLC Patients

The primary objective of this open-label, single arm Phase II trial is to explore the efficacy of BIBW 2992 defined by the objective response rate (CR, PR) as determined by the RECIST crit...

Companies [57 Associated Companies listed on BioPortfolio]

Harbour BioMed

Harbour BioMed is a global biopharmaceutical company discovering and developing innovative therapeutics for cancer, with a focus on immuno-oncology, and immunological diseases. Th...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

BioMed Central Ltd

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical researchAll original research articles published by BioMed Central are made f...

Harbour Point Capital

Harbour Point Capital (“HPC”) is an independent private equity firm specializing in healthcare investing. The co-founders of HPC have worked together for eight years ...

Biomed

Biomed AG wurde 1951 in Zürich gegründet und hat sich seither als Handelsunternehmen für pharmazeutische Produkte im Schweizer Markt etabliert. Biomed ist spezialisiert auf den Handel mit rezeptpfl...

More Information about "Harbour BioMed" on BioPortfolio

We have published hundreds of Harbour BioMed news stories on BioPortfolio along with dozens of Harbour BioMed Clinical Trials and PubMed Articles about Harbour BioMed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Harbour BioMed Companies in our database. You can also find out about relevant Harbour BioMed Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record